Centric Wealth Management boosted its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,695 shares of the company’s stock after purchasing an additional 86 shares during the quarter. Centric Wealth Management’s holdings in Procter & Gamble were worth $1,419,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of PG. HighPoint Advisor Group LLC purchased a new stake in shares of Procter & Gamble in the fourth quarter valued at $17,696,000. Dfpg Investments LLC raised its stake in shares of Procter & Gamble by 1.7% in the fourth quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after acquiring an additional 424 shares during the period. Campbell Wealth Management raised its stake in shares of Procter & Gamble by 13.1% in the fourth quarter. Campbell Wealth Management now owns 1,988 shares of the company’s stock valued at $291,000 after acquiring an additional 231 shares during the period. Herold Advisors Inc. raised its stake in shares of Procter & Gamble by 2.2% in the fourth quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock valued at $3,897,000 after acquiring an additional 581 shares during the period. Finally, V Square Quantitative Management LLC raised its stake in shares of Procter & Gamble by 29.0% in the first quarter. V Square Quantitative Management LLC now owns 43,202 shares of the company’s stock valued at $7,010,000 after acquiring an additional 9,716 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Insider Activity at Procter & Gamble
In related news, CEO R. Alexandra Keith sold 855 shares of the stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the completion of the transaction, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at approximately $634,634. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the completion of the transaction, the insider now directly owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction that occurred on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the transaction, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at $634,634. The disclosure for this sale can be found here. Insiders sold 154,544 shares of company stock valued at $25,413,051 in the last three months. 0.17% of the stock is owned by insiders.
Procter & Gamble Stock Up 0.8 %
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.10. The business had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The company’s revenue was up .6% compared to the same quarter last year. During the same period last year, the business earned $1.37 EPS. As a group, research analysts expect that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.
Procter & Gamble Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were given a $1.0065 dividend. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a dividend yield of 2.44%. The ex-dividend date was Thursday, April 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on PG shares. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. Argus upped their price target on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Barclays upped their price target on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a report on Tuesday, April 23rd. Jefferies Financial Group upped their price target on shares of Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a report on Monday, April 22nd. Finally, BNP Paribas initiated coverage on shares of Procter & Gamble in a report on Monday, June 24th. They issued an “outperform” rating and a $187.00 price target on the stock. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $170.72.
Read Our Latest Stock Report on PG
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
See Also
- Five stocks we like better than Procter & Gamble
- Do ETFs Pay Dividends? What You Need to Know
- MarketBeat Week in Review – 7/1 – 7/5
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Constellation Brands Stock Q1 2025: Crushing Anheuser-Busch?
- How to Invest in Biotech Stocks
- Qualcomm Stock Continues to Rise in the Face of Negative News
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.